Vir Biotechnology (VIR) FCF Margin Growth (3y) (2021 - 2026)
Vir Biotechnology (VIR) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 15,064.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Vir Biotechnology | 1.28 Bn | 1.28 Bn | - | -45.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.76 Mn |
| Dec 31, 2025 | -8,657.00 |
| Sep 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -1.24 Mn |
| Mar 31, 2025 | -267,346.00 |
| Dec 31, 2024 | -72,312.00 |
| Sep 30, 2024 | -721,758.00 |
| Jun 30, 2024 | -263,524.00 |
| Mar 31, 2024 | 433,474.00 |
| Dec 31, 2023 | 386,437.00 |
| Sep 30, 2023 | -326,301.00 |
| Jun 30, 2023 | -1.05 Mn |
| Mar 31, 2023 | 64,502.00 |
| Dec 31, 2022 | 408,411.00 |
| Sep 30, 2022 | 263,717.00 |
| Jun 30, 2022 | 335,562.00 |
| Mar 31, 2022 | 94,379.00 |
| Dec 31, 2021 | 114,903.00 |